Quote Originally Posted by trader_jackson View Post
https://www.nzx.com/announcements/372625

Certainly alot of disruption in FY21 but not that bad after all I suppose + potentially dividends next year + a FY22 forward PE of potentially just 21 (that is below the NZX 50 average)... a dividend and a forward PE below market is pretty rare for a company with a track record of solid top and bottom line growth.
Terrible result.

Revenue only single digit growth (do I hear growth company?), EPS dropped by nearly 25 % from a low base. 7.8 million NPAT, negative earnings growth and a nearly $500 million market cap - something does not fit?

Add to that that other health companies creamed it in the past year - what the hell are AFT doing? This should have been one of its great years ...